Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

Presentation TCT 2025

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

Presenter: Jeehoon Kang

October 28, 2025

Presentation TCT 2025

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 686: Cost-Effectiveness of IVUS and OCT Use for Percutaneous Coronary Intervention Procedures

Presenter: Rory Gallen

October 26, 2025

Presentation TCT 2025

Cost-Effectiveness of CABG vs. PCI for Multivessel Disease: The FAME 3 Trial

Presenter: Mark Andrew Hlatky

October 25, 2025

Presentation TCT 2024

TCT 814: Cost-Effectiveness of Supersaturated Oxygen Delivery for Infarct Size Reduction in Patients With Anterior STEMI

Presenter: Katherine Vilain

October 29, 2024

Presentation TCT 2024

TCT 575: Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI)

Presenter: Tayyab Shah

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

Presenter: Richard Powell

October 28, 2024

Presentation TCT 2023

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

Presenter: Seung Hun Lee

October 26, 2023

Presentation TCT 2023

TCT 385: Ten-Year Review of a Rapid Access Chest Pain Clinic: Efficiency, Cost-effectiveness, and Adaptation to the COVID-19 Pandemic

Presenter: Marwan Shawki

October 24, 2023

Presentation TCT 2023

TCT 106: Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial

Presenter: Joo Myung Lee

October 24, 2023

Presentation TVT 2023

Non-Needle-Based Approach to Transseptal Puncture Using an Electrified 0.32" Guidewire: Large Clinical Experience Demonstrating Safety, Efficacy and Cost-Effectiveness

Presenter: Akash Makkar

June 08, 2023

Presentation TCT 2022

TCT 284: Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients

Presenter: David Hong

September 17, 2022

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Presenter: Hoffmann Udo

September 28, 2019

Presentation TCT 2019

Enabling Early TAVR Patient Ambulation Outside the ICU With the Tempo Lead

Presenter: Stanley Chetcuti

September 26, 2019

Presentation TCT 2019

The Tempo Lead: A New Standard of Care in Temporary Pacing

Presenter: Tamim Nazif

September 26, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Advertisement

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

TCT 686: Cost-Effectiveness of IVUS and OCT Use for Percutaneous Coronary Intervention Procedures

Cost-Effectiveness of CABG vs. PCI for Multivessel Disease: The FAME 3 Trial

TCT 814: Cost-Effectiveness of Supersaturated Oxygen Delivery for Infarct Size Reduction in Patients With Anterior STEMI

TCT 575: Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI)

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

TCT 385: Ten-Year Review of a Rapid Access Chest Pain Clinic: Efficiency, Cost-effectiveness, and Adaptation to the COVID-19 Pandemic

TCT 106: Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial

Non-Needle-Based Approach to Transseptal Puncture Using an Electrified 0.32" Guidewire: Large Clinical Experience Demonstrating Safety, Efficacy and Cost-Effectiveness

TCT 284: Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Enabling Early TAVR Patient Ambulation Outside the ICU With the Tempo Lead

The Tempo Lead: A New Standard of Care in Temporary Pacing

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content